Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Assessment of Frailty in Elderly Patients With Advanced Cancers
Authors not listed
Newcastle-upon-Tyne Hospitals NHS Trust · 2014
Abstract
This study is looking at the feasibility of performing frailty assessments on elderly patients with advanced cancers
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-22 MST
Cite this
APA
Anonymous. (2014). Assessment of Frailty in Elderly Patients With Advanced Cancers. <em>Newcastle-upon-Tyne Hospitals NHS Trust</em>. https://clinicaltrials.gov/study/NCT02482285
Vancouver
Anonymous. Assessment of Frailty in Elderly Patients With Advanced Cancers. Newcastle-upon-Tyne Hospitals NHS Trust. 2014.
BibTeX
@misc{anon2014Assess,
title = {Assessment of Frailty in Elderly Patients With Advanced Cancers},
author = {Anonymous},
journal = {Newcastle-upon-Tyne Hospitals NHS Trust},
year = {2014},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Newcastle-upon-Tyne Hospitals NHS Trust 2013
Open access · US-GOV
Assessment of Frailty in Patients With Advanced Hepatocellular Cancers
Hellenic Oncology Research Group 2003
Open access · US-GOV
A Multicenter Randomized Phase II Study of Docetaxel Versus Vinorelbine as First-Line Treatment in Elderly Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC)
The First Affiliated Hospital with Nanjing Medical University 2020
Open access · US-GOV
Efficacy and Safety of Lenalidomide in Combination With R-GemOx in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma
Fondazione Italiana Linfomi - ETS 2015
Open access · US-GOV
GA101-miniCHOP Regimen for the Treatment of Elderly Unfit Patients With Diffuse Large B-cell Non-Hodgkin's Lymphoma A Phase II Study of the Fondazione Italiana Linfomi (FIL)
Guangdong Provincial People's Hospital 2020
Open access · US-GOV
Lenalidomide Combined With Rituximab as Front-line Therapy in Elderly Patients Aged Over 80 Years With Diffuse Large B Cell Lymphoma
Hellenic Oncology Research Group 2010
Open access · US-GOV